# Jinsoo Lee

> Jinsoo Lee is a seed investor at Shinhan Financial Group (Seoul) backing B2B and SaaS. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Shinhan Financial Group](https://shizune.co/investors/profile/shinhan-financial-group1)
- Location: Seoul, South Korea
- Total investments: 6
- Last investment: Sep 2024
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/jinsoo-lee-9944344a

Jinsoo Lee is a Managing Partner and Head of Global Investment at Shinhan Venture Investment. Before Shinhan, he worked in Korea Investment Bank (IPO), prop-trading, global VC fund investments in Hanwha, and tech/healthcare investments in SK Holdings. He attended Cornell University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| B2B | 1 | 17% |
| SaaS | 1 | 17% |
| Mobile | 1 | 17% |
| Jewelry | 1 | 17% |
| Medical | 1 | 17% |

24 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 33% |
| Series A | 1 | 17% |
| Series B | 1 | 17% |
| Post-IPO Equity | 1 | 17% |
| Venture - Series Unknown | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 2 | 33% |
| United States | 2 | 33% |
| Singapore | 1 | 17% |
| United Kingdom | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Wello | Wello is a government business solution that offers a natural language processing-based business recommendation-application-management service. |  | Series A | Sep 12, 2024 |  |
| MilieMoon | MilieMoon is a global jewelry brand that specializes in offering semi-fine jewelry with a handpicked selection. |  | Seed | Aug 12, 2024 |  |
| QueryPie AI | QueryPie solves the problem of dispersed and chaotic management of enterprise-wide data access to cloud data environments. With an all-in-one solution, users can now simplify data privacy regulations while streamlining access management, reducing costs, and increasing security. |  | Venture - Series Unknown | Mar 03, 2024 |  |
| Speedoc | Speedoc is an industry leader in the digital health space with a mission to provide accessible and affordable healthcare to patients. As a virtual clinic and hospital care provider combining physical-digital services to challenge the traditional centralized, facility-based model, Speedoc believes that this will be the solution to the agingpopulation faced by many countries in the region as the demand for medical care increases. Their services include house call doctors, nurses, medications delivery; and is complemented by telemedicine, remote diagnostics and health monitoring. With Speedoc, home medical services need not be limited to only certain groups of patients, but to everyday people who may require GP or A&E visits for themselves or their loved ones. | $13M | Series B | Nov 08, 2022 |  |
| Bango | Bango is the standard platform chosen by leading global stores to deliver mobile payments to everyone. As the next billion consumers adopt their first smartphone and look for universal payment methods, Bango will be there to unlock the world of apps, video, music, games and other content that brings those smartphones to life. Global stores plugginginto the Bango Payment Platform include Amazon, Google, Samsung and Microsoft. Bango also partners with leading payment providers around the world to drive new users and revenues through its industry-leading mobile payment solutions. Visit: bango.com | $4M | Post-IPO Equity | Apr 17, 2020 |  |
| BreezeBio | GenEdit was founded to transform the delivery of gene therapies and enable the next generation of non-viral, gene editing-based therapeutics. GenEdit’s proprietary technology, NanoGalaxy™ platform solves current delivery challenges by systematically screening its nanoparticle library and providing safer and efficient delivery to target tissues. Thecompany's tool makes therapeutic gene editing possible and is easier to use, faster and more accurate than previous gene-editing techniques and thus has the potential for a wide range of therapeutic applications, enabling physicians to cure incurable genetic diseases. | $8.5M | Seed | Dec 11, 2018 |  |

6 of 6 investments shown.

## Co-investors
- [Bertelsmann Investments](https://shizune.co/investors/profile/bertelsmann-investments) — VC Fund, 1 deal together
- [Bigbang Angels](https://shizune.co/investors/profile/bigbang-angels-inc) — VC Fund, 1 deal together
- [Bow Capital](https://shizune.co/investors/profile/bow-capital) — VC Fund, 1 deal together
- [DCVC Bio](https://shizune.co/investors/profile/dcvc-bio) — VC Fund, 1 deal together
- [Fast Ventures](https://shizune.co/investors/profile/fast-ventures) — VC Fund, 1 deal together
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund, 1 deal together

## About Shinhan Financial Group

VC Fund · Seoul, South Korea

Shinhan Financial Group offers various financial services, including commercial banking, credit card services, securities services, insurance, credit services, and asset management, such as securities investment trust management, investment advisory, call transactions, domestic and foreign private equity fund business, and others.

2 contacts available at Shinhan Financial Group.

| Name | Title | Profile |
| --- | --- | --- |
| Cho Yong Byeong | CEO & Chairman | https://shizune.co/investors/profile/cho-yong-byeong |
| Jinsoo Lee | Head of Global Investment | https://shizune.co/investors/profile/jinsoo-lee |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Jinsoo Lee invest in?

Jinsoo Lee invests primarily in B2B, SaaS and Mobile startups, most often at Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jinsoo Lee last invest?

The most recent investment recorded for Jinsoo Lee closed in Sep 2024. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co
